Medical Mythbusting Commentary for February 1, 2022
If the reported two-dose Pfizer pediatric COVID vaccine data to date for two to four-year-olds did not produce a strong enough immune response, do they have more data to support their application for FDA approval? Play Now | Play in Popup | Download
Pfizer is expected to ask the F.D.A. to authorize its Covid vaccine for children under 5.